Engineer and EPFL graduate Lara Gervaise, cofounder and CEO of Virtuosis AI, combines expertise in health and artificial intelligence. Her start-up develops AI models that analyse vocal biomarkers to detect early signs of conditions such as depression, Parkinson’s and Alzheimer’s diseases, asthma and type 2 diabetes. She will discuss clinical collaborations, applications across neurological and metabolic disorders, and ethical frameworks for protecting personal data while deploying voice‑based diagnostic support tools.
In French.
